VHCP Management II, LLC

13F Portfolio Filings

Most recent 13F
Q4 2019
Location
New York, NY
CIK
0001602263
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q4 2019 20 379,352 TXG, AXSM, CNST, Biohaven Pharmaceuticals 13F-HR 2/13/2020 000095012320001878
Q3 2019 21 262,408 TXG, Biohaven Pharmaceuticals, ASND, SWAV 13F-HR 11/13/2019 000095012319010839
Q2 2019 21 317,188 ASND, SWAV, Biohaven Pharmaceuticals, OBSV 13F-HR 8/13/2019 000095012319007806
Q1 2019 21 341,753 ASND, Biohaven Pharmaceuticals, TCDA, SWAV 13F-HR 5/14/2019 000095012319004909
Q4 2018 19 232,951 Biohaven Pharmaceuticals, ASND, OBSV, BCRX 13F-HR 2/13/2019 000095012319001657
Q3 2018 21 374,474 ECYT, Biohaven Pharmaceuticals, OBSV, ASND 13F-HR 11/13/2018 000095012318011328
Q2 2018 18 334,079 ECYT, Biohaven Pharmaceuticals, OBSV, ASND 13F-HR 8/13/2018 000095012318008382
Q1 2018 17 414,401 AVXS, ECYT, ASND, Biohaven Pharmaceuticals 13F-HR 5/14/2018 000095012318005292
Q4 2017 18 417,194 AVXS, Biohaven Pharmaceuticals, ASND, ARGX 13F-HR 2/13/2018 000095012318001778
Q3 2017 21 361,938 AVXS, Biohaven Pharmaceuticals, ASND, ZGNX 13F-HR 11/13/2017 000095012317010386
Q2 2017 19 250,383 AVXS, Biohaven Pharmaceuticals, ASND, PDSB 13F-HR 8/11/2017 000095012317007498
Q1 2017 20 244,417 AVXS, BCRX, ASND, DBV.PA 13F-HR 5/12/2017 000095012317004811
Q4 2016 22 208,495 AVXS, BCRX, PDSB, DBV.PA 13F-HR 2/13/2017 000095012317001786
Q3 2016 24 194,834 AVXS, BCRX, PDSB, DBV.PA 13F-HR 11/14/2016 000095012316022460
Q2 2016 23 165,687 AVXS, PDSB, DBV.PA, BCRX 13F-HR 8/12/2016 000095012316019771
Q1 2016 22 152,014 AVXS, PDSB, ASND, BCRX 13F-HR 5/13/2016 000095012316017148
Q4 2015 15 121,744 PDSB, RGNX, DBV.PA, ASND 13F-HR 2/12/2016 000095012316014521